Jim Delshad

Director at NeOnc Technologies.

Westlake Village, CA
NeOnc Technologies

Raised on NeOnc Technologies filings

$27.3M

of $53M offered across 4 Form D filings

Form D filings: 4
Teammates: 4
Last filing: Jun 25, 2026

Company

NeOnc Technologies

Biotech · Westlake Village, CA

Intranasal perillyl alcohol for brain tumors

Intranasal perillyl alcohol for brain tumors

Investors: 13
Founded: 2023
Still open: $25.7M

Investors: 13
Sector: Biotech
Founded: 2023
HQ: Westlake Village, CA

NeOnc Technologies filings

NeOnc Technologies Form D filings
Filed	Security	Sold of offered	Filing
Jun 25, 2026	Equity	$5M/ $5M	Form D
Feb 9, 2026	Equity	$10.6M/ $36M	Form D
Apr 11, 2025	Equity	$1.6M/ $2M	Form D
Mar 24, 2025	Equity	$10M/ $10M	Form D

EquityFiled Jun 25, 2026Form D
$5M/ $5M
EquityFiled Feb 9, 2026Form D
$10.6M/ $36M
EquityFiled Apr 11, 2025Form D
$1.6M/ $2M
EquityFiled Mar 24, 2025Form D
$10M/ $10M

Works with

Also named on NeOnc Technologies filings

Amir HeshmatpourChief Executive Officer, Form D signerForm D signer Thomas C. ChenChief Executive Officer, Form D signerForm D signer Amir HeshmatpourDirector Ming-Fu (Alan) ChiangDirector